Article révisé par les pairs
Titre:
  • Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study
Auteur:Campone, Mario; Bachelot, Thomas; Gnant, Michael; Deleu, Ines; Rugo, Hope; Pistilli, Barbara; Noguchi, Shinzaburo; Shtivelband, Mikhail; Pritchard, Kathleen; Provencher, Louise; Burris, Howard H.A.; Hart, Lowell L.L.; Melichar, Bohuslav; Hortobagyi, Gabriel N.; Arena, Francis F.P.; Baselga, José; Panneerselvam, Ashok; Héniquez, Aurelia; El-Hashimyt, Mona; Taran, Tetiana; Sahmoud, Tarek; Piccart-Gebhart, Martine
Informations sur la publication:European journal of cancer, 49, 12, page (2621-2632)
Statut de publication:Publié, 2013-08
Sujet CREF:Cancérologie
Mots-clés:Advanced breast cancer
Everolimus
Exemestane
Visceral metastases
MeSH keywords:Aged
Androstadienes -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- pathology
Clinical Trials, Phase III as Topic
Exanthema -- chemically induced
Fatigue -- chemically induced
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Multicenter Studies as Topic
Neoplasm Metastasis
Placebos
Postmenopause
Prognosis
Randomized Controlled Trials as Topic
Receptor, ErbB-2 -- metabolism
Receptors, Steroid -- metabolism
Sirolimus -- administration & dosage -- adverse effects -- analogs & derivatives
Stomatitis -- chemically induced
Treatment Outcome
Viscera -- pathology
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2013.04.011
info:pii/S0959804913003237
info:scp/84879914608
info:pmid/23735704

Documents en relation

DI-fusion